Cargando…

“We are not the same”: African women’s view of multipurpose prevention products in the TRIO clinical study

PURPOSE: Unintended pregnancy and HIV infection present dual risks for young women in sub-Saharan Africa. New multipurpose prevention technologies (MPTs) are in development to simultaneously prevent unintended pregnancy and HIV, but there is a need for end-user research to ensure these products suit...

Descripción completa

Detalles Bibliográficos
Autores principales: Shapley-Quinn, Mary Kate, Manenzhe, Kgahlisho N, Agot, Kawango, Minnis, Alexandra M, van der Straten, Ariane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369839/
https://www.ncbi.nlm.nih.gov/pubmed/30799959
http://dx.doi.org/10.2147/IJWH.S185712
_version_ 1783394255994093568
author Shapley-Quinn, Mary Kate
Manenzhe, Kgahlisho N
Agot, Kawango
Minnis, Alexandra M
van der Straten, Ariane
author_facet Shapley-Quinn, Mary Kate
Manenzhe, Kgahlisho N
Agot, Kawango
Minnis, Alexandra M
van der Straten, Ariane
author_sort Shapley-Quinn, Mary Kate
collection PubMed
description PURPOSE: Unintended pregnancy and HIV infection present dual risks for young women in sub-Saharan Africa. New multipurpose prevention technologies (MPTs) are in development to simultaneously prevent unintended pregnancy and HIV, but there is a need for end-user research to ensure these products suit women’s needs. The Tablet, Rings and Injectables as Options (TRIO) for women study took place in Kisumu, Kenya, and Soshanguve, South Africa, with the goal of eliciting young women’s feedback on three potential MPTs. METHODS: Women in TRIO used three placebo products that represented potential MPTs: daily oral tablets, monthly vaginal rings, and monthly dual injections in a randomized crossover design followed by a period in which they chose a product to use. Eighty-eight TRIO participants completed in-depth interviews and focus group discussions to understand their experiences using each product. Qualitative analyses were conducted after stratifying by product preference at the end of the crossover period. RESULTS: The majority (65%) of participants preferred injections, with the remainder evenly split between tablets and rings. Discussions of preference for one product were closely linked with expressed dislike of another product’s attributes. Participants recognized heterogeneity in preferences and choices across users and stressed the need for multiple MPT options that confer a low burden on women’s daily lives. CONCLUSION: Rather than choosing a product to use based on the product’s perceived advantages, women’s choices were based on the unfavorable attributes of other TRIO products. Moreover, the importance that women placed on a given disadvantage varied. Disadvantages that women deemed as most important emerged as a greater driver of product preference than selecting products based on their advantages and favorable characteristics.
format Online
Article
Text
id pubmed-6369839
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-63698392019-02-22 “We are not the same”: African women’s view of multipurpose prevention products in the TRIO clinical study Shapley-Quinn, Mary Kate Manenzhe, Kgahlisho N Agot, Kawango Minnis, Alexandra M van der Straten, Ariane Int J Womens Health Original Research PURPOSE: Unintended pregnancy and HIV infection present dual risks for young women in sub-Saharan Africa. New multipurpose prevention technologies (MPTs) are in development to simultaneously prevent unintended pregnancy and HIV, but there is a need for end-user research to ensure these products suit women’s needs. The Tablet, Rings and Injectables as Options (TRIO) for women study took place in Kisumu, Kenya, and Soshanguve, South Africa, with the goal of eliciting young women’s feedback on three potential MPTs. METHODS: Women in TRIO used three placebo products that represented potential MPTs: daily oral tablets, monthly vaginal rings, and monthly dual injections in a randomized crossover design followed by a period in which they chose a product to use. Eighty-eight TRIO participants completed in-depth interviews and focus group discussions to understand their experiences using each product. Qualitative analyses were conducted after stratifying by product preference at the end of the crossover period. RESULTS: The majority (65%) of participants preferred injections, with the remainder evenly split between tablets and rings. Discussions of preference for one product were closely linked with expressed dislike of another product’s attributes. Participants recognized heterogeneity in preferences and choices across users and stressed the need for multiple MPT options that confer a low burden on women’s daily lives. CONCLUSION: Rather than choosing a product to use based on the product’s perceived advantages, women’s choices were based on the unfavorable attributes of other TRIO products. Moreover, the importance that women placed on a given disadvantage varied. Disadvantages that women deemed as most important emerged as a greater driver of product preference than selecting products based on their advantages and favorable characteristics. Dove Medical Press 2019-02-07 /pmc/articles/PMC6369839/ /pubmed/30799959 http://dx.doi.org/10.2147/IJWH.S185712 Text en © 2019 Shapley-Quinn et al. This work is published by Dove Medical Press Limited, and licensed under a Creative Commons Attribution License The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/. The license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Original Research
Shapley-Quinn, Mary Kate
Manenzhe, Kgahlisho N
Agot, Kawango
Minnis, Alexandra M
van der Straten, Ariane
“We are not the same”: African women’s view of multipurpose prevention products in the TRIO clinical study
title “We are not the same”: African women’s view of multipurpose prevention products in the TRIO clinical study
title_full “We are not the same”: African women’s view of multipurpose prevention products in the TRIO clinical study
title_fullStr “We are not the same”: African women’s view of multipurpose prevention products in the TRIO clinical study
title_full_unstemmed “We are not the same”: African women’s view of multipurpose prevention products in the TRIO clinical study
title_short “We are not the same”: African women’s view of multipurpose prevention products in the TRIO clinical study
title_sort “we are not the same”: african women’s view of multipurpose prevention products in the trio clinical study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369839/
https://www.ncbi.nlm.nih.gov/pubmed/30799959
http://dx.doi.org/10.2147/IJWH.S185712
work_keys_str_mv AT shapleyquinnmarykate wearenotthesameafricanwomensviewofmultipurposepreventionproductsinthetrioclinicalstudy
AT manenzhekgahlishon wearenotthesameafricanwomensviewofmultipurposepreventionproductsinthetrioclinicalstudy
AT agotkawango wearenotthesameafricanwomensviewofmultipurposepreventionproductsinthetrioclinicalstudy
AT minnisalexandram wearenotthesameafricanwomensviewofmultipurposepreventionproductsinthetrioclinicalstudy
AT vanderstratenariane wearenotthesameafricanwomensviewofmultipurposepreventionproductsinthetrioclinicalstudy